Lenvatinib mesylate
CAS: 857890-39-2
Ref. TM-T8541
10mg | 40.00 € | ||
25mg | 59.00 € | ||
50mg | 87.00 € | ||
100mg | 109.00 € | ||
200mg | 162.00 € | ||
500mg | 263.00 € |
Product Information
- E7080 (mesylate)
- 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Aminophenoxy)-7-Methoxy-6-Quinolinecarboxamide Mesylate
- 4-[3-Chloro-4-[(cyclopropylaminocarbonyl)amino]phenoxy]-7-methoxy-6-quinolinecarboxamide mesylate
- 6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-, methanesulfonate (1:1)
- 6-Quinolinecarboxamide,4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-,monomethanesulfonate
- E 7080 mesylate
- Kisplyx
- Lenvatinib methanesulfonate
- Lenvima
Lenvatinib mesylate (E7080 (mesylate)) is an oral and multi-targeted inhibitor of VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, with potent antitumor activities.
Chemical properties
Technical inquiry about: TM-T8541 Lenvatinib mesylate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.